Abstract
The 2023 international guideline for the assessment and management of polycystic ovary syndrome introduces several key changes. The updated guideline emphasises holistic patient care that addresses the associated cardiometabolic risks and complications and psychosocial challenges.
| Original language | English |
|---|---|
| Pages (from-to) | 26-33 |
| Number of pages | 8 |
| Journal | Medicine Today |
| Volume | 25 |
| Issue number | 1-2 |
| Publication status | Published - Jan 2024 |
Fingerprint
Dive into the research topics of 'Management of polycystic ovary syndrome : the role of primary care'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver